Xilio Therapeutics Inc (XLO)
1.08
-0.04
(-3.57%)
USD |
NASDAQ |
May 16, 16:00
1.06
-0.02
(-1.85%)
After-Hours: 20:00
Xilio Therapeutics Shares Outstanding: 36.91M for April 25, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
| Date | Value |
|---|---|
| April 25, 2024 | 36.91M |
| April 16, 2024 | 36.91M |
| April 15, 2024 | 36.91M |
| April 12, 2024 | 36.91M |
| March 28, 2024 | 34.47M |
| March 25, 2024 | 27.61M |
| December 31, 2023 | 27.61M |
| November 07, 2023 | 27.54M |
| September 30, 2023 | 27.53M |
| August 04, 2023 | 27.54M |
| June 30, 2023 | 27.52M |
| May 05, 2023 | 27.47M |
| April 14, 2023 | 27.47M |
| March 31, 2023 | 27.44M |
| February 24, 2023 | 27.47M |
| Date | Value |
|---|---|
| December 31, 2022 | 27.43M |
| November 04, 2022 | 27.47M |
| September 30, 2022 | 27.41M |
| August 01, 2022 | 27.47M |
| June 30, 2022 | 27.39M |
| May 04, 2022 | 27.47M |
| April 14, 2022 | 27.47M |
| March 31, 2022 | 27.38M |
| February 15, 2022 | 27.47M |
| December 31, 2021 | 27.36M |
| November 25, 2021 | 27.47M |
| November 01, 2021 | 27.43M |
| October 26, 2021 | 26.67M |
| October 22, 2021 | 26.67M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
26.67M
Minimum
Oct 22 2021
36.91M
Maximum
Apr 12 2024
28.96M
Average
27.47M
Median
Apr 14 2022
Shares Outstanding Benchmarks
| Gilead Sciences Inc | 1.246B |
| FibroGen Inc | 99.48M |
| Avalo Therapeutics Inc | 1.034M |
| IGM Biosciences Inc | 59.02M |
| AEON Biopharma Inc | 21.43M |